Grant
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
This NIH pilot program provides grant funding to US small businesses to transition late-stage NIH-funded SBIR or STTR projects toward commercialization. It supports later-stage R&D, clinical studies, manufacturing scale-up, and regulatory assistance.
See your fitKey facts
- Organiser
- National Institutes of Health
- Deadline
- April 5, 2029
- Opens
- May 28, 2026
- Amount
- Grant
- Open to
- United States
- Stages
- Seed, Series A, Series B and later
- Sectors
- Biotech, Healthtech
3 details are locked
See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.
See your fitKey questions about SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Who can apply to SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)?
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) is aimed at startups at these stages: Seed, Series A, and Series B and later. Eligible locations: United States. The company must be incorporated in United States. Only startups in these sectors qualify: Biotech and Healthtech.
When is the SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) deadline?
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) deadline is April 5, 2029. Applications opened on May 28, 2026.
Other programs in this category
Programs like this in the United States
Verified on September 28, 2026 against the official page.